0001209191-17-065792.txt : 20171214 0001209191-17-065792.hdr.sgml : 20171214 20171214210706 ACCESSION NUMBER: 0001209191-17-065792 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171208 FILED AS OF DATE: 20171214 DATE AS OF CHANGE: 20171214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38052 FILM NUMBER: 171257489 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tocagen Inc CENTRAL INDEX KEY: 0001419041 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261243872 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 BUSINESS PHONE: (858) 412-8400 MAIL ADDRESS: STREET 1: 3030 BUNKER HILL STREET, SUITE 230 CITY: SAN DIEGO STATE: CA ZIP: 92109 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-12-08 0 0001419041 Tocagen Inc TOCA 0001236389 FOLETTA MARK G C/O TOCAGEN INC. 3030 BUNKER HILL, STE. 230 SAN DIEGO CA 92109 0 1 0 0 EVP & Chief Financial Officer Common Stock 2017-12-08 5 J 0 E 2500 8.50 A 7500 D This Form 4 is being filed voluntarily to report the acquisition of 2,500 shares by the Reporting Person on December 8, 2017 pursuant to the Issuer's Employee Stock Purchase Plan. /s/ Mark Foletta 2017-12-14